Stress Echo 2030: The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging.
Eugenio PicanoQuirino CiampiLauro CortigianiAdelaide M Arruda-OlsonClarissa Borguezan DarosJosé Luis de Castro E Silva PrettoRosangela CocchiaEduardo BossoneElisa MerliGarvan C KaneAlbert VargaGergely AgostonMaria Chiara ScaliDoralisa MorroneIana SimovaMartina SamardjievaAlla BoshchenkoTamara RyabovaAlexander VrublevskyAttila PalinkasEszter Dalma PalinkasRobert SeppMarco A R TorresHector R VillarragaTamara Kovacevic PreradovicRodolfo CitroMiguel AmorHugo MostoMichael SalamèPaul LeesonCristina MangiaNicola GaibazziDomenico TuttolomondoCostantina ProtaJesus PeteiroCaroline M Van De HeyningAntonello D'AndreaFausto RigoAleksandra NikolicMiodrag OstojicJorge LowensteinRosina ArbucciDiego M Lowenstein HaberPablo M MerloKarina Wierzbowska-DrabikJaroslaw D KasprzakMaciej HaberkaAna Cristina CamarozanoNithima RatanasitFabio MoriMaria Grazia D'AlfonsoLuigi TassettiAlessandra MilazzoIacopo OlivottoAlberto MarchiHugo G Rodríguez-ZanellaAngela ZagatinaRatnasari PadangMilica DeklevaAna Djordievic-DikicNikola BoskovicMilorad B TesicVojislav GigaBranko BeleslinGiovanni di SalvoValentina LorenzoniMatteo CameliGiulia Elena MandoliTonino BombardiniPio CasoJelena CelutkieneAndrea BarbieriGiovanni BenfariYlenia BartolacelliAlberto Maria LanzoneFrancesca BursiAlessandro MalagoliBruno VillariAntonello RussoMichele De NesClara CarpeggianiInes Paola MonteFederica ReCarlos CotrimGiuseppe BilardoAriel K SaadArnas KaruzasDovydas MatuliauskasPaolo ColonnaFrancesco Antonini-CanterinEugenio PicanoPatricia A Pellikkanull The Stress Echo Study Group Of The Italian Society Of Echocardiography And Cardiovascular Imaging SiecviPublished in: Journal of clinical medicine (2021)
With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: the ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025) ≥10,000 patients followed for ≥5 years (up to 2030) from ≥20 quality-controlled laboratories from ≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.
Keyphrases
- coronary artery disease
- artificial intelligence
- heart failure
- healthcare
- left ventricular
- sars cov
- air pollution
- magnetic resonance
- computed tomography
- high resolution
- hypertrophic cardiomyopathy
- machine learning
- mitral valve
- acute coronary syndrome
- oxidative stress
- risk assessment
- newly diagnosed
- aortic valve
- blood pressure
- big data
- atrial fibrillation
- health information
- brain injury
- chronic obstructive pulmonary disease
- quality improvement
- rectal cancer
- left atrial
- coronary artery bypass grafting
- current status
- diffusion weighted imaging
- diffusion weighted
- prognostic factors
- cardiac resynchronization therapy
- climate change